The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Short answer: FDA has proposed requiring companies to notify the agency when they rely on the GRAS exception for covered human- and animal-food uses. Notices are voluntary under the current system, and the proposal is not yet in force. If finalized, the change would give FDA and the public more information—but filing a notice would not amount to FDA approval.
What does GRAS mean?
GRAS stands for “Generally Recognized as Safe.” Under the Federal Food, Drug, and Cosmetic Act, a substance intentionally added to food generally falls within the food-additive definition, which normally requires premarket review and approval. A use that qualifies as GRAS is an exception to that pathway.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Essentials of Food Science (Food Science Text Series) | $43.32 | Buy on Amazon |
| 2 |
|
The Food Lab: Better Home Cooking Through Science | $23.92 | Buy on Amazon |
| 3 |
|
Food Science: Fifth Edition (Food Science Text Series) | $55.70 | Buy on Amazon |
| 4 |
|
Fennema's Food Chemistry | $84.98 | Buy on Amazon |
| 5 |
|
Food Science: An Ecological Approach: An Ecological Approach | $79.15 | Buy on Amazon |
GRAS applies to a substance under its intended conditions of use; it is not a blanket endorsement of every use or every product containing that substance. For a human-food use to qualify, FDA says the safety data needed to establish safety must be publicly available and the safe use generally recognized by qualified experts. FDA also says the use must meet the same safety standard, supported by the same quantity and quality of information, as a food-additive approval. FDA’s GRAS explainer describes these requirements.
What is the GRAS loophole?
“GRAS loophole” is a critical shorthand for the fact that a company can rely on its own GRAS conclusion without first submitting it to FDA. Under the current system, companies may voluntarily send FDA a GRAS notice, but they are not required to notify the agency just because they are relying on the exception. That can leave FDA with less information about substances being used in food.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Repair Windows errors before they cause bigger problems3Scan for outdated or missing drivers - takes under a minute#1 Best Overall
The phrase does not mean that companies can legally declare any substance safe without meeting a standard. A GRAS conclusion must satisfy the applicable safety and expert-recognition criteria. FDA says a company’s assertion—including an independent assertion—does not necessarily establish that a use legally qualifies as GRAS.
Are GRAS notices mandatory now?
No. As of October 8, 2026, FDA’s mandatory-notice approach is a proposal, not a rule in force. FDA proposed the rule on August 10, 2026; it was published in the Federal Register on August 11 as Substances Generally Recognized as Safe, 91 FR 51834, document 2026-16296. The comment deadline is December 9, 2026, in docket FDA-2025-N-3262. The Federal Register notice says HHS Secretary Robert F. Kennedy Jr. directed FDA on March 10, 2025, to explore rulemaking to eliminate the pathway for firms to introduce purported GRAS uses without notifying FDA of the basis for their conclusions.
Rank #2
- A New York Times Bestseller Winner of the James Beard Award for General Cooking and the IACP Cookbook of the Year Award
What would RFK Jr.’s GRAS rule change?
If finalized, the proposal would generally require a person introducing a human- or animal-food substance into interstate commerce under the GRAS provision to notify FDA of the basis for the conclusion, subject to specified exceptions. In effect, it would convert FDA’s voluntary notification program into a mandatory one for covered uses.
| Question | Current system | FDA’s proposal, if finalized |
|---|---|---|
| Is a notice required? | No; notification is voluntary when a company relies on a GRAS conclusion. | Generally yes for covered human- and animal-food uses, subject to proposed exceptions. |
| What reaches FDA? | A company may submit a notice, but need not do so solely because it relies on GRAS. | The company would generally submit the basis for its conclusion for a covered use. |
| Does filing equal FDA approval? | No. A company’s GRAS conclusion is not automatically an FDA determination. | No. Filing would not itself mean FDA had determined the use to be GRAS. |
| Can the substance be marketed before FDA acts? | The proposal describes the current voluntary framework. | The proposal says a firm could continue marketing a purported GRAS substance before submitting a notice or while FDA’s filing decision is pending. |
The proposal describes exceptions, including a use covered by an existing FDA “no questions” letter and a substance listed or affirmed as GRAS for its intended use in specified regulations. It also proposes a time-limited, streamlined submission route for certain uses of substances already in interstate commerce before a final rule’s effective date. The precise exceptions and transition details could change before a final rule.
Recommended Free Tools
Rank #3
- New
- Mint Condition
- Dispatch same day for order received before 12 noon
- Guaranteed packaging
- No quibbles returns
FDA also proposes treating failure to meet a required notice obligation as one factor when prioritizing substances for post-market review. That is not the same as a requirement to obtain premarket approval for every substance claimed to be GRAS.
What does FDA do with a GRAS notice?
Under the notification program, FDA may respond with a “no questions” letter, say that the notice does not provide a sufficient basis for a GRAS conclusion, or say that it has stopped evaluating the notice at the notifier’s request. A “no questions” response is not an approval of the substance in all circumstances: the conclusion is tied to the notice’s conditions of use. Nor does submitting a notice by itself establish that FDA agrees the use is GRAS.
Rank #4
Why does FDA say the proposal matters?
FDA’s stated rationale is that mandatory notices would give the agency and the public more information about substances used in human and animal food. The agency says that information could help it identify uses that may be unapproved food additives and improve its ability to take action where appropriate. Those are FDA’s reasons for proposing the rule, not proof that it will prevent harm or produce a particular health outcome.
The proposal also carries estimated compliance costs. FDA estimates the rule would cost $89.6 million in present value over 10 years, in 2024 dollars and discounted at 3%, with a range of $34.9 million to $210.0 million. At a 7% discount rate, the agency estimates $82.3 million in present-value costs over 10 years, with a range of $31.5 million to $195.9 million. FDA’s estimated annualized cost at a 3% discount rate is $10.5 million, with a range of $4.1 million to $24.6 million. These are regulatory estimates, not money already spent.
Free tools Windows power users keep installed
One-click scans. No signup required.
Best Value
What happens next?
FDA is seeking public comments through December 9, 2026, under docket FDA-2025-N-3262. The final rule’s requirements, effective date, compliance dates, and eventual impact remain unsettled while the proposal is under consideration. Until a final rule takes effect, the current voluntary-notice framework remains in place.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
